查看購物車
  • Simplified Chinese
  • Japanese
  • Korean
臨床檢驗服務的全球市場:第10版
市場調查報告書
商品編碼
1785094

臨床檢驗服務的全球市場:第10版

Worldwide Market for Clinical Laboratory Services, 10th Edition
出版日期: | 出版商: Kalorama Information | 英文 270 pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

"全球臨床實驗室服務市場：第十版" 對全球臨床實驗室服務產業進行了權威分析，提供了關於2024年至2029年市場規模、成長動力、需求檢測類型以及競爭定位的競爭洞察。本報告對於希望了解COVID-19疫情發展過程中診斷服務動態的利害關係人而言，是重要的資源。

為何本報告對體外診斷 (IVD) 製造商至關重要

Kalorama Information 的這份年度報告對於體外診斷 (IVD) 製造商至關重要。臨床實驗室是體外診斷 (IVD) 市場的核心，為從遺傳疾病、傳染病到慢性病和腫瘤等各種疾病的診斷、監測和治療提供重要見解。 70-80% 的臨床診斷是透過實驗室檢測進行的，因此這些服務對於現代醫療保健服務至關重要。

實驗室服務市場機遇，第十版

本報告第十版對臨床檢測現況進行了深入評估，重點在於影響全球檢測需求的發展動態。從歷史市場趨勢到當前及預測數據，本報告可協助企業評估其績效並為未來變革做好準備。

報告主要特點

  • 行業概覽：詳細了解臨床檢測行業，包括其歷史淵源、在醫療保健領域不斷發展的作用以及對門診和遠端檢測日益增長的依賴。
  • 重要統計數據：分析人口結構變化、疾病趨勢、預期壽命以及影響臨床檢測行業的更廣泛的醫療保健環境。
  • 全球聚焦： 區域細分
    • 北美(美國，加拿大)
    • EMEA(德國，法國，義大利，西班牙，英國，瑞士)
    • 亞太地區(日本，中國，印度，韓國，澳洲)
    • 南美(巴西，墨西哥)

成為對象的專門領域

  • 必需及例行檢查:臨床化學，血液學，凝固學，內分泌學
  • 免疫學及微生物學檢驗
  • 細胞學及組織學檢驗
  • 遺傳基因檢驗
  • 毒物學檢驗(濫用藥物)
  • COVID-19檢驗

實驗室各類型市場區隔

  • 獨立型檢驗機關及標準檢驗機關
  • 醫院為基礎的檢驗室
  • 診所為基礎的檢驗機關

競爭分析:

關於本報告提供臨床檢驗服務供應商各公司的市場策略，各地區的優勢，醫療提供模式和償付結構的變化相對應的調整詳述，刊載了全面的競爭檢討。

資料與預測
基準年 2024年
過去資料 2019年～2024年
預測期間 2025年～2029年
年複合成長率: 關於全部的主要市場區隔提供
市場層級 服務供應商/廠商層級的收益

課題與調整：

本報告的每一版均會更新，以反映新興的行業趨勢，包括定價壓力、報銷改革、整合趨勢以及持續的影響。 COVID-19。我們也考慮了營運方面的轉變，例如對家庭和門診護理的依賴程度增加，這些轉變正在推動診斷服務的新需求模式。

排除項

本報告不包括臨床檢測、獸醫實驗室、環境檢測、檢體採集和運輸等輔助服務的收入。

目錄

調查關於公司

第1章 摘要整理

第2章 產業概要

  • 臨床檢測描述
  • 各國家/地區臨床實驗室人員組成
  • 最大的臨床檢測市場：美國
  • 實驗室自主研發的檢測法規
  • 付款人和報銷
  • 價格透明度
  • 直接面向消費者的偵測
  • 擴大癌症檢測的使用率和技術
  • 資訊科技的作用
  • 產業推動因素

第3章 專門各領域的檢驗服務

  • 檢驗和服務概要
  • 臨床化學- 日常檢驗和必需檢驗
  • 免疫學和微生物學
  • 細胞診斷及組織診斷檢驗
  • 遺傳基因檢驗
  • 毒性實驗

第4章 供應商各群組世界臨床檢驗市場

  • 臨床檢驗市場:供應商概要
  • 醫院及急性期照護提供者
  • 醫生和門診病人診療提供者
  • 獨立型檢驗機關

第5章 北美市場

  • 概要
  • 美國
  • CLIA檢驗室登記，各類型檢驗室
  • 美國的醫院資料
  • 加拿大

第6章 歐洲，中東·非洲(EMEA)市場

  • 概要
  • 主要市場
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 瑞士

第7章 亞太地區市場

  • 概要
  • 主要國家
    • 日本
    • 日本臨床檢驗產業結構
    • 中國
    • 中國的臨床檢驗產業結構
    • 印度
    • 澳洲
    • 韓國

第8章 南美市場

  • 概要
  • 主要國家
    • 巴西
    • 墨西哥

第9章 主要市場參與企業

  • 世界競爭企業摘要
  • 企業簡介
  • ARUP LABORATORIES
  • BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
  • DAVITA
  • EUROFINS SCIENTIFIC SE
  • EXACT SCIENCES CORP.
  • GUARDANT HEALTH
  • H.U. GROUP HOLDINGS
  • LABORATORY CORPORATION OF AMERICA
  • MEDICOVER AB
  • MYRIAD GENETICS, INC.
  • NATERA
  • QUEST DIAGNOSTICS, INC.
  • SIEMENS HEALTHINEERS
  • SONIC HEALTHCARE LIMITED
  • SYNLAB INTERNATIONAL GMBH
  • UNILABS

第10章 市場趨勢和摘要

  • 全球市場概要
  • 地區概要
    • 人口成長
    • 高齡化社會
    • 疾病負擔加重
    • 發展中地區經濟成長
    • 已開發地區經濟穩定
    • 價格壓力
    • 專注於高效的醫療保健系統
    • 整體醫療服務需求成長
    • COVID-19
    • 多重偵測
    • 人工智慧與機器學習實驗室趨勢
    • 分子檢測和其他高階檢測開闢新途徑
    • 數位病理趨勢
    • 人員短缺
簡介目錄
Product Code: 25-034KA

"Worldwide Market for Clinical Laboratory Services, 10th Edition" provides a definitive analysis of the global clinical lab services industry, offering critical insights into market size, growth drivers, testing types in demand, and competitive positioning from 2024 to 2029. This report is a key resource for stakeholders seeking to understand diagnostic service dynamics in the wake of COVID-19's transition to endemic status.

Why This Report is Essential for IVD Manufacturers

This annual review by Kalorama Information is indispensable for IVD manufacturers. Clinical laboratories are the core of the in vitro diagnostics (IVD) market, delivering essential insights for diagnosis, monitoring, and treatment across a wide range of conditions-from genetic and infectious diseases to chronic illnesses and oncology. With 70-80% of clinical diagnoses informed by lab tests, these services remain integral to modern healthcare delivery.

Market Opportunity in Lab Services: Now in Its 10th Edition

The 10th edition of this report offers an in-depth assessment of the clinical laboratory landscape, highlighting developments that are shaping global testing demand. From historical market trends to current and forecasted data, the report helps companies benchmark performance and prepare for future shifts.

Key Features of the Report:

  • Industry Overview: Presents a detailed exploration of the clinical laboratory sector, including its historical roots, evolving role in healthcare, and the growing reliance on outpatient and remote testing.
  • Influential Statistics: Analyzes demographic shifts, disease incidence trends, life expectancy, and the broader healthcare environment impacting the clinical lab industry.
  • Global Focus: Regional breakdowns include:
    • North America (United States, Canada)
    • EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
    • Asia Pacific (Japan, China, India, South Korea, Australia)
    • Latin America (Brazil, Mexico)

Specialty Segments Covered:

  • Essential and Routine Testing: Clinical chemistry, hematology, coagulation, and endocrinology
  • Immunology and Microbiology Testing
  • Cytology and Histology Testing
  • Genetic Testing
  • Toxicology Testing (Drugs of Abuse)
  • COVID-19 Testing

Market Segmentation by Laboratory Type:

  • Independent and Reference Laboratories
  • Hospital-based Laboratories
  • Clinic-based Laboratories

Competitive Analysis:

The report includes a comprehensive competitive review of top clinical laboratory service providers, detailing their market strategies, regional strengths, and adjustments in response to shifting healthcare delivery models and reimbursement structures.

Data and Forecasting
    Base Year:          2024
    Historical Data:          2019-2024
    Forecast Period:          2025-2029
    CAGRs:          Provided for all major segments
    Market Level:          Service provider/manufacturer level revenues

Challenges and Adjustments:

Each edition of the report is revised to reflect new industry developments, including pricing pressures, reimbursement reform, consolidation trends, and the continued impact of COVID-19. It also considers operational shifts such as increased reliance on home-based and outpatient care settings, driving new demand patterns for diagnostic services.

Exclusions:

The report excludes revenues from clinical trial testing, veterinary labs, environmental testing, and ancillary services such as specimen collection and transportation.

TABLE OF CONTENTS

ABOUT KALORAMA INFORMATION

CHAPTER ONE: EXECUTIVE SUMMARY

  • INDUSTRY AT A GLANCE
    • Figure 1-1: Worldwide Market for Clinical Laboratory Services Snapshot, 2025 (Market Overview, Key Service Providers, World Regions)
  • SCOPE AND METHODOLOGY
  • GLOBAL MARKET OVERVIEW
    • Figure 1-2: Factors Growing Clinical Lab Demands, 2025
    • Table 1-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
    • Figure 1-3: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
  • KEY ISSUES AND TRENDS AFFECTING THE MARKET
  • LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

  • CLINICAL LABORATORY DESCRIPTION
    • Figure 2-1: Clinical Labatory Order
    • Figure 2-2: Hospital Length of Stay in Days, by Country, 2021 Average (Australia, Austria, Belgium, Canada, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States)
    • Laboratory Service Payer Types
      • Table 2-1: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
      • Figure 2-3: Clinical Laboratory Revenues, by Client and Payer Type, Estimated 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
  • NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY
    • Figure 2-4: Laboratory Health Workers, by Country, 2010-2021 Average (Argentina, Australia, Brazil, Canada, China, India, Indonesia, Mexico, Republic of Korea, South Africa, United Kingdom, United States)
  • THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES
    • Structure and Regulation in the U.S.
    • Certificate of Waiver
      • Table 2-2: Selected CLIA Waived Laboratory Tests
    • Certificate of Provider-Performed Microscopy Procedures (PPMP)
      • Table 2-3: Provider-Performed Microscopy Procedures
    • Certificate of Compliance and Certificate of Accreditation
      • Figure 2-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), April 2024 (%)
      • Table 2-4: Clinical Laboratory Certificates Issued, by State and by Type (non-exempt laboratories only), as of April 2024
      • Figure 2-6: Laboratory Certificate Trends, by Application Type, July 2010-April 2024 (Accreditation, Compliance, PPM, Waiver)
    • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
      • Table 2-5: CLIA Exempt States, Number of Laboratories, as of April 2024
  • LABORATORY DEVELOPED TEST REGULATIONS
    • Directive 2017/746 (IVDR)
  • PAYERS AND REIMBURSEMENT
    • Figure 2-7: Positive Forces and Negative Forces Impacting Clinical Laboratory Services, 2025
    • Trends in Medicare Reimbursement
      • Figure 2-8: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2024
    • Protecting Access to Medicare Act (PAMA) of 2014
      • Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2026
    • Saving Access to Laboratory Service Act (SALSA)
    • Advanced Laboratory Tests (ADLT)
      • Table 2-7: List of Approved ADLTs, March 2025
    • Bundled Insurance Payments for ESRD Patients
      • Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2025)
    • Commercial Insurance Providers
      • Table 2-9: National Commercial Insurance Provider List Revenues, 2024
      • Figure 2-9: National Commercial Insurance Providers by Membership and Total Revenues, 2024 ($ billion)
  • TRANSPARENCY IN PRICING
    • Figure 2-10: Revenue and Test Volume Trends, Quest Diagnostics, 2010-2024 ($ million) (volume million)
  • DIRECT-TO-CONSUMER TESTING
    • Table 2-10: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Labcorp On Demand), 2023 (US $)
  • EXPANDING CANCER TEST UTILIZATION AND TECHNOLOGIES
    • Labcorp Acquires Select Assets of Invitae
    • Labcorp Launches Plasma Detect
    • Quest Launches MelaNodal Predict Test
    • Labcorp Launches First CDx Assay for Gastric Cancer Patients
    • Labcorp Expands Molecular Residual Disease and Liquid Biopsy Solutions
    • Quest Develops Multi-Cancer Stratification Blood Test
  • THE ROLE OF INFORMATION TECHNOLOGY
    • Table 2-11: Selected Laboratory Information Management System Providers, 2024 Vendor List
  • INDUSTRY DRIVERS
    • Global Demographics
      • Table 2-12: The Global Population, 1980-2060 (millions)
      • Figure 2-11: The Global Population, 1980-2060 (millions)
    • Regional Population Overview
      • Table 2-13: World Population by UN Defined Geographic Region, 2010-2060 (millions)
      • Figure 2-12: World Population by UN Defined Geographic Region, 2010-2060 (millions)
    • Aging Populations
      • Table 2-14: Global Population Trends Age 65+, 2000-2060 (millions)
      • Figure 2-13: Global Population Trends Age 65+, 2000-2060 (millions)
    • Chronic Diseases and Conditions
      • Figure 2-14: Global Prevalence of Disease, 2000, 2015, and Projected 2030
      • Figure 2-15: Leading Causes of Death Globally, by Number of Deaths, 2021 (millions)
    • Economic Performance
    • Health Expenditures
      • Figure 2-16: Global Health Spending as a Percentage of GDP, by Country, 2023 estimates (%) (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, the Netherlands, Poland, Russia, South Korea, Saudi Arabia, South Africa, Spain, Turkey, United Kingdom, United States)
    • Laboratory Performance Drivers and Challenges
    • Drivers
    • Challenges

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

  • TEST AND SERVICES OVERVIEW
    • Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2019-2029 ($ million)
    • Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-2: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-3: Global Clinical Laboratory Market Analysis, Segment Growth Forecast, CAGR 2024-2029 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-4: Global Clinical Laboratory Market Analysis, by Testing Service, Distribution of Revenues, 2024 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
  • CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING
    • Figure 3-5: Global Clinical Laboratory Market Analysis: Clinical Chemistry - Routine & Essential Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-2: Market Overview - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Figure 3-6: Market Revenue - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Figure 3-7: Market Share - Routine and Essential Testing, by Service Segment, 2024 (%) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Routine Clinical Chemistry
    • Cholesterol Level Testing
      • Table 3-3: High Cholesterol Risk Categories
    • Urinalysis
      • Table 3-4: Normal Reference Levels in a Medical Urinalysis
    • Hematology
    • Blood Cell Count
      • Table 3-5: Laboratory Reference Parameters for CBC
    • Coagulation
    • Endocrinology
    • Thyroid Function Tests
    • Pregnancy Testing
      • Table 3-6: hCG Levels in Pregnant Women by Days Past Ovulation
  • IMMUNOLOGY AND MICROBIOLOGY
    • Figure 3-8: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-7: Market Overview - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Figure 3-9: Market Revenue - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Figure 3-10: Market Share - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Allergy and Food Intolerance
    • Tumor Markers
    • Cardiac Markers
    • HIV Testing
  • CYTOLOGY AND HISTOLOGY TESTING
    • Figure 3-11: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-8: Market Overview - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Figure 3-12: Market Revenue - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Figure 3-13: Market Share - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Pap Test
      • Figure 3-14: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country, 2019 Estimates (%) (Canada, China, France, Germany, Hungary, India, Israel, Italy, Japan, The Netherlands, Poland, Romania, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
      • Figure 3-15: Summary Recommendations: WHO Suggests Using the Following Strategy for Cervical Cancer Prevention, 2021
  • GENETIC TESTING
    • Figure 3-16: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-9: Market Overview - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
    • Figure 3-17: Market Revenue - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
    • Figure 3-18: Market Share - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
  • TOXICOLOGY TESTING
    • Figure 3-19: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-10: Substance Detection Periods, by Selected Test Method

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

  • CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW
    • Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment, 2024 and 2029 (Hospitals, Independent, Physician Offices/Outpatient Clinics)
    • Figure 4-1: Global Clinical Laboratory Market Analysis: Provider Segment Growth Forecast, CAGR 2024-2029 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
    • Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues, 2024 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
  • HOSPITALS AND ACUTE CARE PROVIDERS
    • Figure 4-3: COVID-19 Impact on Hospital-based Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-4: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-5: Hospital Beds per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
    • Figure 4-6: Global Visualization - Hospital Beds per 1,000 Population, by Country, 2023/2024
  • PHYSICIANS AND OUTPATIENT CARE PROVIDERS
    • Figure 4-7: COVID-19 Impact on Physician-based Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-8: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Physician Offices
      • Figure 4-9: Medical Doctors per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
      • Figure 4-10: Global Visualization - Medical Doctors per 1,000 Population, by Country, 2023/2024
    • Global Nursing Establishments and Assisted Living Facilities
    • Global Dialysis Clinics
  • INDEPENDENT LABORATORY PROVIDERS
    • Figure 4-11: COVID-19 Impact on Independent Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-4: Revenues for Selected U.S.-based Reference Labs, 2019-2024 ($ million)* (Bio-Reference Lab/OPKO, Labcorp, Quest Diagnostics)
    • Table 4-5: Estimated Clinical Test Volume, by Select Independent Laboratory, 2024 (millions of units) (Bio-Reference Lab/Opko, Eurofins Scientific, Labcorp, Medicover, Natera, NeoGenomics, Quest Diagnostics, Sonic Healthcare, Unilabs)
    • Table 4-6: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-12: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)

CHAPTER FIVE: NORTH AMERICA MARKET

  • OVERVIEW
    • Table 5-1: North America Market Value, by Country, 2024 ($ million)* (United States, Canada & other regions)
    • Figure 5-1: North America Clinical Laboratory Service Revenues, by Country, 2024-2029 ($ million)* (Canada and United States)
    • Figure 5-2: North America Clinical Laboratory Service Share, by Country, 2024 (%) (United States, Canada & other regions)
  • UNITED STATES
    • Table 5-2: United States Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Figure 5-3: United States Clinical Laboratory Service Market Performance, 2019-2029 ($ million)
    • U.S. Market by Test Type
      • Table 5-3: United States Clinical Laboratory Service Market, by Testing Service Type, Estimates and Forecast 2024-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
      • Figure 5-4: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Testing Service Type, 2019-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
      • Figure 5-5: United States Clinical Laboratory Market Analysis: Testing Service Revenue Share, by Testing Service Type, 2024 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
    • U.S. Market by Laboratory Provider Type
      • Table 5-4: United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2024-2029 ($ million) (Hospital-based, Independent, Physician-based)
      • Figure 5-6: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Laboratory Type, 2019-2029 ($ million) (Hospital-based, Independent, Physician-based)
      • Figure 5-7: United States Clinical Laboratory Market Share, by Laboratory Type, 2024 (%) (Hospital-based, Independent, Physician-based)
    • U.S. Clinical Laboratory Industry Structure
      • Figure 5-8: Growth in Clinical Laboratories, 2000-2024
  • CLIA Laboratory Registration, Laboratories by Type
    • Figure 5-9: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory Type, May 2024
    • Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), May 2024
    • Figure 5-10: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined) June 2020 and May 2024
    • Figure 5-11: Percent Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, Compounded Annually, 2020-2024 (%)
    • Independent Clinical Laboratories
      • Figure 5-12: Leading U.S. Independent Laboratory Groups, Distribution of Centers, December 2024 (%)
    • Growth in Independent Clinical Laboratories
      • Figure 5-13: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024
    • Hospital-based Laboratories
  • U.S. Hospital Data
    • Table 5-6: U.S. Hospital Types
    • Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2010-2023
    • Table 5-8: AHA Statistics for U.S. Hospitals, 2014-2023
    • U.S. Hospital Stay Stats
      • Figure 5-14: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021 (# days of hospital stay)
    • Growth in Hospital Clinical Laboratories
      • Figure 5-15: Growth in U.S. Hospital Laboratory Locations, June 2011-April 2024
    • Physician-Office and Clinic Laboratories
    • Number of U.S. Physicians
    • Growth in Clinical Laboratories in Physician Offices
      • Figure 5-16: Growth in U.S. Physician Office Laboratory Locations, June 2011-April 2024
    • Nursing Facility and Home Health
    • U.S. Nursing Home Establishments
    • U.S. Home Health Facilities
    • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
      • Figure 5-17: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011-April 2024
    • Pharmacy-based Laboratories
    • Growth in Pharmacy-Based Clinical Laboratories
      • Figure 5-18: Growth in U.S. Pharmacy-Based Laboratories, mid-2011-April 2024
    • Dialysis Clinics
    • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
      • Figure 5-19: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011-April 2024
  • CANADA
    • Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Figure 5-20: Canada Clinical Laboratory Service Market, Performance 2019-2029 ($ million)

CHAPTER SIX: EUROPE, THE MIDDLE EAST, AND AFRICA (EMEA) MARKET

  • OVERVIEW
    • Table 6-1: EMEA Market Value, by Country, 2024 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
    • Figure 6-1: EMEA Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom)
    • Figure 6-2: EMEA Clinical Laboratory Service Market Share, by Country, 2024 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
    • Figure 6-3: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
  • KEY MARKETS
    • Germany
      • Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2024-2029 ($ million)
      • Figure 6-4: Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, Germany, 2024 (%) (Eurofins, IMD - Medicover, Siemens, Sonic, SYNLAB, Others)
    • France
      • Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Italy
      • Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Spain
      • Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • United Kingdom
      • Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Switzerland
      • Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER SEVEN: ASIA PACIFIC (APAC) MARKET

  • OVERVIEW
    • Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-2: Asia Pacific Clinical Laboratory Service Market Share, by Country, 2024 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-3: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
  • KEY COUNTRIES
    • Japan
      • Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Japan Clinical Laboratory Industry Structure
      • Figure 7-4: Japan Clinical Laboratory Industry, by Type, 2024 (%)
      • Figure 7-5: Japan Clinical Laboratory Industry, by Test Classification, 2023-2024 (%) (Basic (essential/routine), Non-Basic, Pathology, Other Test Services)
      • Figure 7-6: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2024 (%)
    • China
      • Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • China Clinical Laboratory Industry Structure
      • Figure 7-7: China Clinical Laboratory Industry, by Type, 2024 (%)
    • India
      • Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Australia
      • Table 7-5: Australia Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • South Korea
      • Table 7-6: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER EIGHT: LATIN AMERICA MARKET

  • OVERVIEW
    • Table 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Brazil, Mexico, Rest of Latin America)
    • Figure 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Brazil, Mexico, Rest of Latin America)
    • Figure 8-2: Latin America Clinical Laboratory Service Market Share, by Country, 2024 (%) (Brazil, Mexico, Rest of Latin America)
    • Figure 8-3: Latin America Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2024-2029 (%) (Brazil, Mexico, Rest of Latin America)
  • KEY COUNTRIES
    • Brazil
      • Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Mexico
      • Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER NINE: LEADING MARKET PARTICIPANTS

  • GLOBAL COMPETITOR SUMMARY
    • Figure 9-1: Market Participants, Global Service Revenues, Estimated 2023 and 2024 ($ million)
    • U.S. COMPETITIVE ANALYSIS
      • Table 9-1: Top Ten Estimated U.S. Laboratory Service Revenues ($ million) and Market Share (%) of Leading Clinical Laboratory Providers, 2024
      • Figure 9-2: Top 10 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2024 (%)
  • SELECT COMPANY PROFILES
  • ARUP LABORATORIES
    • Company Overview
      • Table 9-2: ARUP Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
    • Company Overview
      • Table 9-3: BioReference Health Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • DAVITA
    • Company Overview
      • Table 9-4: DaVita Corporate Details
    • Products and Services
  • EUROFINS SCIENTIFIC SE
    • Company Overview
      • Table 9-5: Eurofins Scientific Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • EXACT SCIENCES CORP.
    • Company Overview
      • Table 9-6: Exact Sciences Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • GUARDANT HEALTH
    • Company Overview
      • Table 9-7: Guardant Health Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • H.U. GROUP HOLDINGS
    • Company Overview
      • Table 9-8: H.U. Group Holdings, Inc. Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • LABORATORY CORPORATION OF AMERICA
    • Company Overview
      • Table 9-9: Laboratory Corporation of America Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • MEDICOVER AB
    • Company Overview
      • Table 9-10: Medicover Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • MYRIAD GENETICS, INC.
    • Company Overview
      • Table 9-11: Myriad Genetics Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • NATERA
    • Company Overview
      • Table 9-12: Natera Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • QUEST DIAGNOSTICS, INC.
    • Company Overview
      • Table 9-13: Quest Diagnostics Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SIEMENS HEALTHINEERS
    • Company Overview
      • Table 9-14: Siemens Healthineers Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SONIC HEALTHCARE LIMITED
    • Company Overview
      • Table 9-15: Sonic Healthcare Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SYNLAB INTERNATIONAL GMBH
    • Company Overview
      • Table 9-16: SYNLAB Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • UNILABS
    • Company Overview
      • Table 9-17: Unilabs Corporate Details
    • Products and Services

CHAPTER TEN: MARKET TRENDS AND SUMMARY

  • GLOBAL MARKET OVERVIEW
    • Table 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)*
    • Figure 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
  • REGIONAL OVERVIEW
    • Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-3: Global Clinical Laboratory Service Market Share, Revenues by Region, 2024 (%) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-4: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2024-2029 (%) (Asia Pacific, EMEA, Latin America, North America)
    • Population Growth
    • Aging Populations
    • Increasing Disease Burden
    • Economic Growth in Developing Regions
    • Stabilizing Economies in Developed Regions
    • Pricing Pressures
    • Focus on Efficient Health Systems
    • Overall Growth in Demand for Healthcare Services
    • COVID-19
    • Multiplex Testing
    • AI and Machine Learning Laboratory Trends
    • Molecular Testing and Other Advanced Testing Will Open New Avenues
    • Digital Pathology Trends
    • Staffing Shortages